Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

Vitamin D and Calcium Deficiency and its Relationship with Cardiac Function in Patients with Beta-Thalassemia

Document Type : Original Article

Authors

1 Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

2 Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

3 Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

Abstract

 
 Background: Heart disease is the leading cause of mortality and morbidity in patients with beta-thalassemia. Vitamin D and calcium deficiency are common in these patients. We studied and compared vitamin D and calcium levels and other parameters with echocardiographic findings in patients with beta-thalassemia.
Methods: A cross-sectional study on patients with transfusion-dependent thalassemia was conducted. One hundred sixty-nine patients with transfusion-dependent thalassemia were enrolled. Ejection fraction, valvular insufficiency, and aortic diameter were determined. The aortic diameter of patients was measured using the Mindray DC60 echo model. All of these patients were tested for levels of vitamin D, calcium (Ca), parathyroid hormone (PTH), alkaline phosphatase (ALP), platelet (PLT), and ferritin. Finally, the effect of these factors on aortic root (AR), aortic valve area (AVA), and ejection fraction (EF) was evaluated. One-way ANOVA was used to compare quantitative variables, and a chi-square test with a 95% confidence level was used to estimate relationships and compare ratios in groups.
Results: A statistically significant relationship existed between vitamin D deficiency and serum Ca (P value = 0.009). Our results showed that EF also increased with the increase in vitamin D levels, and the probability that the AR would have a normal size increased. Furthermore, abnormal PTH and PLT levels caused a decrease in EF.
Conclusion: This study showed an association between vitamin D deficiency and cardiac function in patients with transfusion-dependent thalassemia. Vitamin D can be considered a supplement for thalassemia patients.

Highlights

Maryam Ahmadipour(google scholar)(pubmed)

Ahmad Naghibzadeh-Tahami(google scholar)(pubmed)

Koroush Mirzie(google scholar)(pubmed)

elham maleki(google scholar)(pubmed)

Keywords

Main Subjects

References
  1. Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011;118(13):3479-88. doi: 10.1182/blood-2010-08-300335.
  2. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11. doi: 1186/1750-1172-5-11.
  3. Shiri R, Mahdieh N. An overview on thalassemia: genetics of beta thalassemia in Iran. Koomesh. 2005;17(1):1-17. [Persian].
  4. Khorasani G, Kosaryan M, Vahidshahi K, Shakeri S, Nasehi MM. Results of the national program for prevention of beta-thalassemia major in the Iranian province of Mazandaran. Hemoglobin. 2008;32(3):263-71. doi: 1080/03630260802004269.
  5. Miri M, Tabrizi Namini M, Hadipour Dehshal M, Sadeghian Varnosfaderani F, Ahmadvand A, Yousefi Darestani S, et al. Thalassemia in Iran in last twenty years: the carrier rates and the births trend. Iran J Blood Cancer. 2013;6(1):11-7. [Persian].
  6. Fahim FM, Saad K, Askar EA, Eldin EN, Thabet AF. Growth parameters and vitamin D status in children with thalassemia major in upper Egypt. Int J Hematol Oncol Stem Cell Res. 2013;7(4):10-4.
  7. Betts M, Flight PA, Paramore LC, Tian L, Milenković D, Sheth S. Systematic literature review of the burden of disease and treatment for transfusion-dependent β-thalassemia. Clin Ther. 2020;42(2):322-37.e2. doi: 1016/j.clinthera.2019.12.003.
  8. Jamshidi K, Abdollahzad H, Nachvak M, Rezaei M, Golpayegani MR, Sharifi Zahabi E. Effects of alpha-lipoic acid supplementation on cardiovascular disease risk factors in β-thalassemia major patients: a clinical trial crossover study. J Blood Med. 2020;11:131-9. doi: 2147/jbm.s252105.
  9. Khamseekaew J, Kumfu S, Chattipakorn SC, Chattipakorn N. Effects of iron overload on cardiac calcium regulation: translational insights into mechanisms and management of a global epidemic. Can J Cardiol. 2016;32(8):1009-16. doi: 1016/j.cjca.2015.10.012.
  10. Wood JC, Claster S, Carson S, Menteer JD, Hofstra T, Khanna R, et al. Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol. 2008;141(6):891-4. doi: 1111/j.1365-2141.2008.07135.x.
  11. de Vernejoul MC, Girot R, Gueris J, Cancela L, Bang S, Bielakoff J, et al. Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocrinol Metab. 1982;54(2):276-81. doi: 1210/jcem-54-2-276.
  12. Gözü Pirinççioğlu A, Gökalp D, Söker M. Parathyroid functions in thalassemia major patients. Ann Clin Endocrinol Metab. 2017;1:15-9. doi: 29328/journal.acem.1001003 .
  13. Pala M, Bhat KG, Manya S, Joseph N, Harish S. Vitamin D levels and left ventricular function in beta-thalassemia major with iron overload. Eur J Pediatr. 2023;182(4):1749-54. doi: 1007/s00431-023-04830-7.
  14. Pilz S, Kienreich K, Tomaschitz A, Lerchbaum E, Meinitzer A, März W, et al. Vitamin D and cardiovascular disease: update and outlook. Scand J Clin Lab Invest Suppl. 2012;243:83-91. doi: 3109/00365513.2012.681972.
  15. Dejkhamron P, Wejaphikul K, Mahatumarat T, Silvilairat S, Charoenkwan P, Saekho S, et al. Vitamin D deficiency and its relationship with cardiac iron and function in patients with transfusion-dependent thalassemia at Chiang Mai University Hospital. Pediatr Hematol Oncol. 2018;35(1):52-9. doi: 1080/08880018.2018.1424280.
  16. Ozdemir O, Olgunturk R, Kula S, Tunaoglu FS. Echocardiographic findings in children with Marfan syndrome. Cardiovasc J Afr. 2011;22(5):245-248. doi:5830/CVJA- 2010-085.
  17. Oztarhan K, Delibas Y, Salcioglu Z, Kaya G, Bakari S, Bornaun H, et al. Assessment of cardiac parameters in evaluation of cardiac functions in patients with thalassemia major. Pediatr Hematol Oncol. 2012;29(3):220-34. doi: 3109/08880018.2012.671449.
  18. Ghaemian A, Hoseini A, Kosarian M. Left ventricular diastolic abnormalities in thalassemia major with normal systolic function. Med J Islam Repub Iran. 2002;16(1):9-12.
  19. Chahkandi T, Kazemi T, Jalili A, Ghaderi F. Evaluation of cardiac function in patients with major beta thalassemia in Birjand. Sci J Iran Blood Transfus Organ. 2013;10(1):86-92. [Persian].
  20. Taher AT, Saliba AN. Iron overload in thalassemia: different organs at different rates. Hematology Am Soc Hematol Educ Program. 2017;2017(1):265-71. doi: 1182/asheducation-2017.1.265.
  21. Jian J, Yang Q, Dai J, Eckard J, Axelrod D, Smith J, et al. Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. Free Radic Biol Med. 2011;50(7):841-7. doi: 1016/j. freeradbiomed.2010.12.028.
  22. Kabat GC, Rohan TE. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control. 2007;18(10):1047-53. doi: 1007/s10552-007- 9058-9.
  23. Wood JC, Enriquez C, Ghugre N, Otto-Duessel M, Aguilar M, Nelson MD, et al. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N Y Acad Sci. 2005;1054:386-95. doi: 1196/annals.1345.047.
  24. Saadatifar H, Mohaghegh H, Ahmadi M, Moshkani farahani M. Relationship between the plasma levels of vitamin D and magnesium and cardiac involvement and iron overload in thalassemia major patients referred to Ganjavian Hospital of Dezful in 2018. Iran Heart J. 2021;22(4):15-24.
  25. Koca Yozgat A, Azak E, Kaçar D, Işık M, Arman Bilir Ö, Güzelküçük Z, et al. The effects of vitamin D on myocardial function demonstrated by speckle-tracking echocardiography in children with beta thalassemia. Turk Kardiyol Dern Ars. 2023;51(5):328-32. doi: 5543/tkda.2023.85265.
  26. Hagag AA, El-Shanshory MR, Abo El-Enein AM. Parathyroid function in children with beta thalassemia and correlation with iron load. Adv Pediatr Res. 2015;2(3):1-6. doi: 12715/ apr.2015.2.3.
  27. Saki F, Salehifar A, Kassaee SR, Ranjbar Omrani G. Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study. BMC Nephrol. 2020;21(1):482. doi: 1186/s12882-020-02101-3.
  28. Manolopoulos PP, Lavranos G, Mamais I, Angouridis A, Giannakou K, Johnson EO. Vitamin D and bone health status in beta thalassemia patients-systematic review. Osteoporos Int. 2021;32(6):1031-40. doi: 1007/s00198-021-05821-w.
  29. Saki F, Ranjbar Omrani G. Evaluation of serum fibroblast growth factor-23 in patients with beta-thalassemia major compared to healthy population. Iran J Pediatr Hematol Oncol. 2022;12(3):182-9. doi: 18502/ijpho.v12i3.10061.
  30. Nitsa A, Toutouza M, Machairas N, Mariolis A, Philippou A, Koutsilieris M. Vitamin D in cardiovascular disease. In Vivo. 2018;32(5):977-81. doi: 21873/invivo.11338.
  31. Guessous I, Bochud M, Bonny O, Burnier M. Calcium, vitamin D and cardiovascular disease. Kidney Blood Press Res. 2011;34(6):404-17. doi: 1159/000328332.
  32. Pishgahi M, Niroomand M, Bozorgmehr R, Ghane-Fard S, Mousavi F, Tabary M, et al. Association between serum vitamin D level and echocardiographic abnormalities in patients with thalassemia major. Cardiovasc Hematol Disord Drug Targets. 2020;20(3):214-20. doi: 2174/1871529x20 666200701104931.
  33. Wood JC. Cardiac complications in thalassemia major. Hemoglobin. 2009;33(Suppl 1):S81-6. doi: 3109/03630260903347526.
  34. Rai V, Agrawal DK. Role of vitamin D in cardiovascular diseases. Endocrinol Metab Clin North Am. 2017;46(4):1039- 59. doi: 1016/j.ecl.2017.07.009.
  35. Goyal M, Abrol P, Lal H. Parathyroid and calcium status in patients with thalassemia. Indian J Clin Biochem. 2010;25(4):385-7. doi: 1007/s12291-010-0071-5.
  36. Pu F, Chen N, Xue S. Calcium intake, calcium homeostasis and health. Food Sci Hum Wellness. 2016;5(1):8-16. doi: 1016/j.fshw.2016.01.001.

 

Journal of Kerman University of Medical Sciences
Volume 31, Issue 1
March and April 2024
Pages 29-34
Files
Share
How to cite
Statistics